How is the Citius Oncology Inc. today?

The Citius Oncology Inc. today is trading in the green, up by 2.17% at 0.94.

What is Citius Oncology Inc. Annual Net Profit?

Citius Oncology Inc. Annual Net Profit fell 974.17% in the last year to $21.15 M. Its sector's average net profit growth for the last fiscal year was 10.5%.

What is Citius Oncology Inc. Stock Price?

Citius Oncology Inc. Stock Price fell 91.73% and underperformed its sector by 114.84% in the past year.

What is Citius Oncology Inc. Quarterly Net profit?

Citius Oncology Inc. Quarterly Net profit fell 59.97% YoY to $7.74 M. Its sector's average net profit growth YoY for the quarter was 3.94%.

What is Citius Oncology Inc. Debt to Equity Ratio?

Citius Oncology Inc. Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Citius Oncology Inc. Return on Equity(ROE)?

Citius Oncology Inc. Return on Equity(ROE) for the last financial year was -59.01%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Citius Oncology Inc. Mutual Fund Holding?

Citius Oncology Inc. Mutual Fund Holding remained the same in the last quarter at 10.39%.

What is Citius Oncology Inc. Institutional Holding?

Citius Oncology Inc. Institutional Holding decreased by 0.14% in the last quarter to 60.92.

Citius Oncology Inc. XNAS: CTOR

Citius Oncology Inc. Live Share Price Today, Share Analysis and Chart

Name: Citius Oncology Inc.: Is Infosys Ltd. worth buying?
Item: Citius Oncology Inc.
Rating: 1.09041675
Author: Trendlyne DVM scores

about

TenX Keane Acquisition is a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

0.94 0.02 (2.17%)

98.08% Fall from 52W High

38,433 XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Citius Oncology Inc. took place on 04 Jun 2025, for the purpose of Citius Oncology Inc Annual General Meeting for 2024 See details

Not Eligible

-

Expensive Valuation

4.7 / 100

Technically Neutral

39.0 / 100

No estimates available

Citius Oncology Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Citius Oncology Inc. FAQ

How is Citius Oncology Inc. today?

Citius Oncology Inc. today is trading in the green, and is up by 2.17% at 0.94.

How has Citius Oncology Inc. performed historically?

Citius Oncology Inc. is currently trading up 2.17% on an intraday basis. In the past week the stock rose 5.62%. stock has been down -13.76% in the past quarter and fell -91.73% in the past year. You can view this in the overview section.